Counterfeit Semaglutide Causes Hypoglycemic Coma: Dangerous Fake Drug Warning
Case report of hypoglycemic coma caused by a falsified semaglutide product highlights the dangerous consequences of counterfeit GLP-1 drug products entering the market.
Quick Facts
What This Study Found
Case report of hypoglycemic coma caused by a falsified semaglutide product highlights the dangerous consequences of counterfeit GLP-1 drug products entering the market.
Key Numbers
31-year-old woman admitted with hypoglycemic coma after using a falsified semaglutide product.
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide evidence.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Evidence comparison?
- ?Next steps?
Trust & Context
- Key Stat:
- Key finding Case report of hypoglycemic coma caused by a falsified semaglutide product highlights the dangerous
- Evidence Grade:
- Based on design.
- Study Age:
- Published in 2025.
- Original Title:
- Hypoglycaemic coma induced by a falsified semaglutide product: a case report.
- Published In:
- European journal of hospital pharmacy : science and practice (2025)
- Authors:
- Antonacci, Giulia, Bortignon, Erika, Bolognesi, Massimo, Piano, Salvatore Silvio, Cadore, Alessandro, Camuffo, Laura, Venturini, Francesca, Faoro, Sonia, Favretto, Donata, Romano, Antonietta, Mengato, Daniele
- Database ID:
- RPEP-09953
Evidence Hierarchy
Frequently Asked Questions
What does this mean?
Case report of hypoglycemic coma caused by a falsified semaglutide product highlights the dangerous consequences of counterfeit GLP-1 drug products entering the market.
How reliable?
Consult publication.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09953APA
Antonacci, Giulia; Bortignon, Erika; Bolognesi, Massimo; Piano, Salvatore Silvio; Cadore, Alessandro; Camuffo, Laura; Venturini, Francesca; Faoro, Sonia; Favretto, Donata; Romano, Antonietta; Mengato, Daniele. (2025). Hypoglycaemic coma induced by a falsified semaglutide product: a case report.. European journal of hospital pharmacy : science and practice. https://doi.org/10.1136/ejhpharm-2025-004656
MLA
Antonacci, Giulia, et al. "Hypoglycaemic coma induced by a falsified semaglutide product: a case report.." European journal of hospital pharmacy : science and practice, 2025. https://doi.org/10.1136/ejhpharm-2025-004656
RethinkPeptides
RethinkPeptides Research Database. "Hypoglycaemic coma induced by a falsified semaglutide produc..." RPEP-09953. Retrieved from https://rethinkpeptides.com/research/antonacci-2025-hypoglycaemic-coma-induced-by
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.